Finance

Lists
600196:SHA
Shanghai Fosun Pharmaceutical (Group) Ord Shs A
CN¥ 23.19
-0.34%
(-0.080) 1D
10-р сарын 15, 15:00:02 (GMT+8)  ·   CNY
All symbols
SymbolPriceChange% Change
Generating top insights for 600196...
Open
CN¥ 23.10
High
CN¥ 23.52
Low
CN¥ 22.90
Mkt. cap
57.71 тэрбум
Avg. vol.
18.77 сая
Volume
16.97 сая
Dividend
1.68%
Quarterly dividend
CN¥ 0.10
Ex-dividend date
2026 оны 7-р сарын 27
P/E ratio
18.04
52-wk high
CN¥ 29.68
52-wk low
CN¥ 20.85
EPS
CN¥ 1.29
Shares outstanding
2.01 тэрбум
No. of employees
41 мян
Open
CN¥ 23.10
High
CN¥ 23.52
Low
CN¥ 22.90
Mkt. cap
57.71 тэрбум
Avg. vol.
18.77 сая
Volume
16.97 сая
Dividend
1.68%
Quarterly dividend
CN¥ 0.10
Ex-dividend date
2026 оны 7-р сарын 27
P/E ratio
18.04
52-wk high
CN¥ 29.68
52-wk low
CN¥ 20.85
EPS
CN¥ 1.29
Shares outstanding
2.01 тэрбум
No. of employees
41 мян
News stories
From web sources and news partners
ad-hoc-news.de
ad-hoc-news.de
·
1 цагийн өмнө
Fosun Pharma stock has October 27 results on its calendar
Profile
Shanghai Fosun Pharmaceutical Co., Ltd. is a Chinese pharmaceutical company. It is mostly owned by Fosun International. As of 2018, the A shares of the company is a constituent of SSE 180 Index as well as its sub-index SSE MidCap Index. The company was ranked 1,840th in 2020 edition of the Forbes Global 2000, a list of top listed companies of the world. Wikipedia
About Shanghai Fosun Pharmaceutical (Group) Ord Shs A
CEOLiu Yi | Wen Deyong
Employees40.7 мян
Founded1994
Headquarters-
SectorPharmaceutical industry
Previous reportsAll values in CNY
Loading Previous Earnings...
Revenue
Net income
All values in CNY
2025 оны 9-р сар
2025 оны 12-р сар
2026 оны 3-р сар
2026 оны 6-р сар
Revenue
9.88 тэрбум
12.27 тэрбум
10.07 тэрбум
10.37 тэрбум
Cost of goods sold
5.08 тэрбум
5.65 тэрбум
5.07 тэрбум
5.23 тэрбум
Cost of revenue
5.08 тэрбум
5.65 тэрбум
5.07 тэрбум
5.23 тэрбум
Research and development expenses
1.01 тэрбум
1.28 тэрбум
896.79 сая
1.19 тэрбум
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
3.10 тэрбум
4.44 тэрбум
3.27 тэрбум
3.35 тэрбум
Operating expense
4.04 тэрбум
5.92 тэрбум
4.19 тэрбум
4.63 тэрбум
Total operating expenses
9.12 тэрбум
11.57 тэрбум
9.26 тэрбум
9.86 тэрбум
Operating income
758.38 сая
699.05 сая
813.78 сая
505.27 сая
Other non operating income
-116.85 сая
107.33 сая
2.03 сая
-13.28 сая
EBT including unusual items
1.12 тэрбум
1.27 тэрбум
1.36 тэрбум
1.23 тэрбум
EBT excluding unusual items
1.49 тэрбум
1.10 тэрбум
1.21 тэрбум
1.07 тэрбум
Income tax expense
162.98 сая
82.80 сая
277.92 сая
159.73 сая
Effective tax rate
14.57%
6.50%
20.47%
13.00%
Other operating expenses
-92.19 сая
117.57 сая
19.04 сая
74.01 сая
Net income
821.33 сая
847.27 сая
870.83 сая
850.64 сая
Net profit margin
8.31%
6.91%
8.64%
8.20%
Earnings per share
-
-
-
-
Interest and investment income
1.05 тэрбум
732.13 сая
689.67 сая
938.86 сая
Interest expense
-321.25 сая
-291.32 сая
-296.51 сая
-310.88 сая
Net interest expenses
727.28 сая
440.80 сая
393.16 сая
627.98 сая
Depreciation and amortization charges
-
-
-
-
EBITDA
1.39 тэрбум
1.47 тэрбум
1.59 тэрбум
1.24 тэрбум
Gain or loss from assets sale
2.12 сая
-69.35 сая
-
-195.23 мян
AI content may include mistakes. Learn more
Google аппс